A number of firms have modified their ratings and price targets on shares of Vitamin Shoppe (NYSE: VSI) recently:

  • 8/15/2017 – Vitamin Shoppe was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “
  • 8/10/2017 – Vitamin Shoppe had its price target lowered by analysts at Barclays PLC from $13.00 to $6.00. They now have an “equal weight” rating on the stock.
  • 8/10/2017 – Vitamin Shoppe had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $7.00 price target on the stock, down previously from $14.00.
  • 8/10/2017 – Vitamin Shoppe had its “sell” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). They now have a $6.00 price target on the stock, down previously from $13.00.
  • 8/10/2017 – Vitamin Shoppe was given a new $8.00 price target on by analysts at Morgan Stanley. They now have a “hold” rating on the stock.
  • 8/9/2017 – Vitamin Shoppe was downgraded by analysts at TheStreet from a “c-” rating to a “d” rating.
  • 7/27/2017 – Vitamin Shoppe was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/18/2017 – Vitamin Shoppe was upgraded by analysts at Zacks Investment Research from a “strong sell” rating to a “hold” rating. According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

Vitamin Shoppe, Inc (NYSE VSI) opened at 5.75 on Tuesday. The firm has a 50-day moving average price of $9.58 and a 200 day moving average price of $15.16. Vitamin Shoppe, Inc has a 1-year low of $5.70 and a 1-year high of $28.41. The stock’s market cap is $133.53 million.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. The company had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. Vitamin Shoppe’s revenue for the quarter was down 8.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.55 EPS. On average, equities research analysts anticipate that Vitamin Shoppe, Inc will post $0.82 EPS for the current fiscal year.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.